Liu W, Wang X H, Yang X J, Zhang X Y, Qi W J
Department of Intensive Care Unit, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
Zhonghua Yi Xue Za Zhi. 2016 Nov 29;96(44):3568-3572. doi: 10.3760/cma.j.issn.0376-2491.2016.44.007.
To investigate the relationship between related factors of intestinal barrier dysfunction in patients with sepsis or septic shock and severity of the condition. A prospective observational study was conducted in 31 sepsis patients, 28 septic shock patients, and 21 postoperative patients without sepsis (control group) who were admitted to intensive care unit (ICU) of General Hospital of Ningxia Medical University between November 2015 and June 2016. Blood samples were collected from the patients within 24 hours following admission to ICU. D-lactic acid and endotoxin levels were measured by enzymatic method, serum high-sensitivity C-reactive protein (hsCRP) level by immune scatter turbidimetry. An arterial blood gas (ABG) measurement was carried out every 8 hours within the first 24 hours after admission to ICU, and average arterial blood lactate levels were calculated. Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) score, Sequential Organ Failure Assessment (SOFA) score of the patients within 24 hours following ICU admission were recorded. The patients with sepsis or septic shock were followed up for 28 days after admission to ICU, and divided into survival group (=44) and death group (=15). The patients with sepsis or septic shock were divided into two groups according to the site of infection, i. e. intra-abdominal infection group (=37) and extra-abdominal infection group (=22). (1) In the control, sepsis, and septic shock groups, D-lactic acid [mg/L, (, ) ] were 11.68(7.49, 14.92), 19.78 (12.25, 34.85), and 32.45 (16.03, 46.95), respectively; endotoxin levels [U/L, (, )] were 10.60(7.59, 13.39), 16.12(10.09, 20.23), and 17.31(14.09, 23.77), respectively. The levels of serum D-lactic acid and endotoxin in the patients with sepsis or septic shock were significantly higher than those in the control group (all <0.01); while no statistically significant differences existed in these two indices between the sepsis and septic shock groups (both >0.05). There were no statistically significant differences in serum D-lactic acid and endotoxin levels between the intra-abdominal infection group and the extra-abdominal infection group [20.07(14.70, 38.97)vs 21.65 (14.53, 56.56)mg/L; 17.23(13.38, 20.85)vs 17.17(9.93, 20.81)U/L; both >0.05]. There were no statistically significant differences in levels of serum D-lactic acid and endotoxin between the survival group and the death group [21.65(15.11, 39.00) vs 19.78(14.41, 80.93)mg/L; 17.09(12.62, 20.42) vs 19.26(13.22, 26.27)U/L, both >0.05]. (2) In the sepsis and septic shock patients, serum D-lactate level was significantly related to mean arterial blood lactate concentration, APACHE Ⅱ score, and SOFA score in the first 24 hours after admission to ICU (=0.499, 0.447, 0.469, all <0.01); serum endotoxin level was correlated with hsCRP, APACHE Ⅱ score, and SOFA score (=0.224, 0.388, 0.393, all <0.05). (3) Multivariate linear regression analysis showed that D-lactic acid level was independently associated with average arterial blood lactate concentration as well as with SOFA score(=0.34, =19.91, <0.01), and endotoxin was independently associated with only SOFA score(=0.14, =12.68, <0.01). Regardless of the site of infection, patients with sepsis or septic shock often have intestinal barrier injury, which is correlated with the severity of disease, but does not independently affect patient outcome. Tissue hypoperfusion in the early stage of sepsis may be one of the causes of intestinal barrier injury.
探讨脓毒症或脓毒性休克患者肠道屏障功能障碍相关因素与病情严重程度的关系。选取2015年11月至2016年6月在宁夏医科大学总医院重症监护病房(ICU)收治的31例脓毒症患者、28例脓毒性休克患者及21例无脓毒症的术后患者(对照组)进行前瞻性观察研究。患者入ICU后24小时内采集血样,采用酶法测定D-乳酸和内毒素水平,用免疫散射比浊法测定血清高敏C反应蛋白(hsCRP)水平。入ICU后24小时内每8小时进行1次动脉血气(ABG)检测,并计算动脉血乳酸平均水平。记录患者入ICU后24小时内的急性生理与慢性健康状况评分Ⅱ(APACHEⅡ)及序贯器官衰竭评估(SOFA)评分。对脓毒症或脓毒性休克患者入ICU后随访28天,分为存活组(=44)和死亡组(=15)。将脓毒症或脓毒性休克患者按感染部位分为两组,即腹腔内感染组(=37)和腹腔外感染组(=22)。(1)对照组、脓毒症组和脓毒性休克组D-乳酸[mg/L,(,)]分别为11.68(7.49,14.92)、19.78(12.25,34.85)和32.45(16.03,46.95);内毒素水平[U/L,(,)]分别为10.60(7.59,13.39)、16.12(10.09,20.23)和17.31(14.09,23.77)。脓毒症或脓毒性休克患者血清D-乳酸和内毒素水平显著高于对照组(均<0.01);而脓毒症组和脓毒性休克组这两项指标差异无统计学意义(均>0.05)。腹腔内感染组与腹腔外感染组血清D-乳酸和内毒素水平差异无统计学意义[20.07(14.70,38.97)vs 21.65(14.53,56.56)mg/L;17.23(13.38,20.85)vs 17.17(9.93,20.81)U/L;均>0.05]。存活组与死亡组血清D-乳酸和内毒素水平差异无统计学意义[21.65(15.11,39.00)vs 19.78(14.41,80.93)mg/L;17.09(12.62,20.42)vs 19.26(13.22,26.27)U/L,均>0.05]。(2)在脓毒症和脓毒性休克患者中,血清D-乳酸水平与入ICU后24小时内的动脉血乳酸平均浓度、APACHEⅡ评分及SOFA评分显著相关(=0.499,0.447,0.469,均<0.01);血清内毒素水平与hsCRP、APACHEⅡ评分及SOFA评分相关(=0.224,0.388,0.393,均<0.05)。(3)多因素线性回归分析显示,D-乳酸水平与动脉血乳酸平均浓度及SOFA评分独立相关(=0.34,=19.91,<0.01),内毒素仅与SOFA评分独立相关(=0.14,=12.68,<0.01)。无论感染部位如何,脓毒症或脓毒性休克患者常存在肠道屏障损伤,其与疾病严重程度相关,但不独立影响患者预后。脓毒症早期的组织低灌注可能是肠道屏障损伤的原因之一。